Metraipolis › archive › dc_525ce623a2d7

Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II… — Europe PMC PMID:41299684

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41299684
DOI
10.1186/s13045-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-08T05:44:52.661Z
SHA-256 of the archived text
3527c6bec6d45c4d51fc55732a8b753ee09d77e0f8451427761797ead4a1b766
Stable URL of this page
https://metraipolis.com/documento/dc_525ce623a2d7

How to cite

Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II… — Europe PMC PMID:41299684 — Europe PMC (en), https://europepmc.org/article/MED/41299684 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_525ce623a2d7 (Metraipolis archive dc_525ce623a2d7, sha256 3527c6bec6d45c4d51fc55732a8b753ee09d77e0f8451427761797ead4a1b766)
BibTeX
@misc{dc525ce623a2d7,
  title = {Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II… — Europe PMC PMID:41299684},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41299684},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_525ce623a2d7; sha256 3527c6bec6d45c4d51fc55732a8b753ee09d77e0f8451427761797ead4a1b766},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41299684. Agents can read the archived copy with the MCP tool read_document.